Filter
134
Text search:
drogen
Featured
12
23
Language
Document type
45
29
18
14
7
6
6
3
2
1
1
1
1
Countries / Regions
47
8
3
3
2
1
1
1
1
1
Authors & Publishers
Publication Years
Category
9
8
3
3
2
2
1
Toolboxes
51
39
24
19
6
3
3
2
2
2
1
1
Guidance liefert Informationen rund um Alkohol, Medikamente, Drogen und Suchtgefahren. Die App richtet sich vorrangig an Geflüchtete, die sich über den Umgang mit verschiedenen Substanzen informieren möchten oder Rat suchen, z.B. weil sie in Bezu
...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
Estimated annual number of deaths from drug use disorders per 100,000 people.
Estimated annual number of deaths from drug use disorders, by type of drug.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
Presentation
Infection and Drug Resistance 2020:13 4047–4060
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Severe Malaria Observatory (SMO) is a global knowledge platform designed to enable professionals working on severe malaria, such as researchers, clinicians, public health experts, programme managers, policymakers and technical partners, to access, share and analyse reliable data on malaria compl
...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa and Asia, the consortium conducted over 25 studies
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a
...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme
...
